Evolent Health, Inc. Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

Evolent Health, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $1.88 billion for the year ending 2025.

  • Evolent Health, Inc. showed a decrease of -26.6% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
  • This data is from Evolent Health, Inc.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
  • XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2017: $106.24 million | Q2 2017: $107.07 million | Q3 2017: $107.91 million | Q4 2017: $113.73 million | Q1 2018: $139.71 million | Q2 2018: $144.30 million | Q3 2018: $149.95 million | Q4 2018: $193.10 million | Q1 2019: $197.76 million | Q2 2019: $191.96 million | Q3 2019: $220.14 million | Q4 2019: $236.53 million | Q1 2020: $247.29 million | Q2 2020: $238.63 million | Q3 2020: $264.59 million | Q4 2020: $271.92 million | Q1 2021: $215.07 million | Q2 2021: $222.06 million | Q3 2021: $222.47 million | Q1 2022: $297.06 million | Q2 2022: $319.94 million | Q3 2022: $352.59 million | Q1 2023: $427.69 million | Q2 2023: $469.14 million | Q3 2023: $511.02 million | Q4 2023: $556.06 million | Q1 2024: $639.65 million | Q2 2024: $647.15 million | Q3 2024: $621.40 million | Q4 2024: $646.54 million | Q1 2025: $483.65 million | Q2 2025: $444.33 million | Q3 2025: $479.53 million | Q4 2025: $468.72 million.
  • Over the full 10 years of available data (2016 to 2025), Evolent Health, Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 638.1%.
  • Historical annual values: Fiscal year 2025: $1.88 billion | Fiscal year 2024: $2.55 billion | Fiscal year 2023: $1.96 billion | Fiscal year 2022: $1.35 billion | Fiscal year 2021: $907.96 million | Fiscal year 2020: $924.64 million | Fiscal year 2019: $846.38 million | Fiscal year 2018: $627.06 million | Fiscal year 2017: $434.95 million | Fiscal year 2016: $254.19 million.
  • Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: